Exploring Immunological, Microbial, and Other Contributing Factors in the Deterioration of Health among Patients with Uncontrolled Diabetes: A Community-based Study to Identify Causes and Solutions
DOI:
https://doi.org/10.31185/bsj.Vol21.Iss38.933Keywords:
Uncontrolled diabetes; Oral fungal infection; Candida species; Quality of life; Sexual dysfunction; Chronic disease management; Immunological statusAbstract
Uncontrolled diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistently elevated blood glucose levels due to insufficient insulin production, impaired insulin action, or both. The Uncontrolled-DM remains a major public health problem due to its association with multiple health complications. This study aimed to evaluate microbial, immunological, and other contributing factors associated with health deterioration among patients compared with healthy controls. The structured questionnaire was used to collect the data on the basis of the guidelines of the American Diabetes Association and was tested on the pilot study, and on the basis of Cronbach's alpha. Moreover, two hindered oral swab samples were gathered and examined on the basis of traditional microbiological procedures and the VITEK 2 Compact system to determine fungal agents. Additionally, HbA1c, IAA, ANA, and ESR were measured. The outcomes indicated that the prevalence of oral fungal infections was much higher in diabetic patients, and Candida albicans was the most common one. The level of inflammatory markers were high significant increasing in the patients compared to control, poor sexual life and work capacity, along with a high rate of negative emotional feelings, were also observed in diabetic patients, implying a high psychological burden. The findings indicate the multi-dimensional effects of uncontrolled diabetes on immunological, microbial, and psychosocial health. In addition to this, demographics and education were discovered to be factors that affected disease awareness and healthcare satisfaction. The presence of microbial infections, an increase in the level of inflammatory markers, and suffering highlight the importance of multidimensional patient management plans beyond glycemic control. In conclusion: this study has shown that uncontrolled diabetes is also linked to higher vulnerability to oral diseases, dysfunction in the immune system, lower quality of life, and psychological impairment. It is important to include oral screening, immunological markers, psychological assistance, and multidisciplinary care in the program of diabetes management to achieve a better clinical outcome and overall living standards in this demographic.
References
1. Akpan, A., & Morgan, R. (2002). Oral candidiasis. Postgraduate Medical Journal, 78(922), 455–459. https://doi.org/10.1136/pmj.78.922.455
2. Aldahmashi, H., Maneze, D., Molloy, L., & Salamonson, Y. (2024). Nurses' adoption of diabetes clinical practice guidelines in primary care and the impacts on patient outcomes and safety: An integrative review.. International journal of nursing studies, 154, 104747. https://doi.org/10.1016/j.ijnurstu.2024.104747
3. Alexander, M., Cho, E., Gliozheni, E., Salem, Y., Cheung, J., & Ichii, H. (2024). Pathology of Diabetes-Induced Immune Dysfunction. International Journal of Molecular Sciences, 25. https://doi.org/10.3390/ijms25137105
4. Ali, M., Ali, F., Gerstle, D., Zehra, A., & Fazli, G. (2025). Community-based type 2 diabetes screening programmes designed for priority populations: a scoping review protocol. BMJ Open, 15. https://doi.org/10.1136/bmjopen-2024-090787
5. Alsous, M., Jalil, M., Odeh, M., Kurdi, R., & Alnan, M. (2019). Public knowledge, attitudes and practices toward diabetes mellitus: A cross-sectional study from Jordan. PLoS ONE, 14. https://doi.org/10.1371/journal.pone.0214479
6. American Diabetes Association. (2023). Standards of care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S1–S291. https://doi.org/10.2337/dc23-Sint
7. American Diabetes Association. (2024). Standards of medical care in diabetes—2024. Diabetes Care, 47 (Supplement_1), S1–S350. https://doi.org/10.2337/dc24-Sint
8. Anafo, R., Atiase, Y., Kotey, F., Dayie, N., Tetteh-Quarcoo, P., Duodu, S., Osei, M., Alzahrani, K., & Donkor, E. (2021). Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital. PLoS ONE, 16. https://doi.org/10.1371/journal.pone.0257004
9. Asrie, A., Belete, T., Misker, M., Beyna, A., Ayele, H., Tekle, K., Milikit, Y., Andargie, E., Afework, H., Lenjiso, Y., & Legese, G. (2025). Assessment of glycemic control, health-related quality of life, and associated factors in type 2 diabetic patients attending a comprehensive specialized hospital in Northwest Ethiopia. PLOS One, 20. https://doi.org/10.1371/journal.pone.0332628
10. Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The Lancet, 383(9911), 69–82. https://doi.org/10.1016/S0140-6736(13)60591-7
11. Baral, P., Afnan, N., Zahra, M., Akter, B., Prapti, S., Hossan, M., & Haque, F. (2024). Bacteriological analysis and antibiotic resistance in patients with diabetic foot ulcers in Dhaka. PLOS ONE, 19. https://doi.org/10.1371/journal.pone.0301767
12. Basevi, V. (2011). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 34, S62 - S69. https://doi.org/10.2337/dc11-s062
13. Birhanu, N., Mamo, G., Shiferaw, G., Gizachew, D., Belayneh, F., & Birhanu, T. (2025). Factors affecting diabetes related hospitalization and in-hospital outcomes of adults with diabetes in south Ethiopia: A prospective observational study. PLOS One, 20. https://doi.org/10.1371/journal.pone.0330735
14. Blasco-Blasco, M., Puig-García, M., Piay, N., Lumbreras, B., Hernández-Aguado, I., & Parker, L. (2020). Barriers and facilitators to successful management of type 2 diabetes mellitus in Latin America and the Caribbean: A systematic review. PLoS ONE, 15. https://doi.org/10.1371/journal.pone.0237542
15. Carrillo-Larco, R., Anza-Ramírez, C., Saal‐Zapata, G., Villarreal-Zegarra, D., Zafra-Tanaka, J., Ugarte-Gil, C., & Bernabé-Ortiz, A. (2021). Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis. Journal of Epidemiology and Community Health, 76, 75 - 84. https://doi.org/10.1136/jech-2020-216029
16. Carter, N., Li, J., Xu, M., Li, L., Xu, S., Fan, X., Zhu, S., Chahal, P., & Chattopadhyay, K. (2023). Lifestyle behaviours and associated factors among people with type 2 diabetes attending a diabetes clinic in Ningbo, China: A cross-sectional study. PLOS ONE, 18. https://doi.org/10.1371/journal.pone.0294245
17. Chefik, F., Tadesse, T., Quisido, B., & Roba, A. (2022). Adherence to insulin therapy and associated factors among type 1 and type 2 diabetic patients on follow up in Madda Walabu University Goba Referral Hospital, South East Ethiopia. PLoS ONE, 17. https://doi.org/10.1371/journal.pone.0269919
18. Chowdhury, M., Uddin, M., Khan, H., & Haque, M. (2015). Type 2 diabetes and its correlates among adults in Bangladesh: a population based study. BMC Public Health, 15. https://doi.org/10.1186/s12889-015-2413-y
19. Conrad, N., Judge, A., Tran, J., Mohseni, H., Hedgecott, D., Crespillo, A. P., ... & Cleland, J. G. F. (2018). Temporal trends and patterns in heart failure incidence: A population based study of 4 million individuals. The Lancet, 391(10120), 10–16. https://doi.org/10.1016/S0140-6736(17)32520 5
20. Dera, A., Alghamdi, A., Al-Shahrani, M., Al-Gahtani, R., Alghamdi, B., Zaman, G., Rasheed, M., Al-Shehri, H., Al-Qhtani, L., Ali, S., Hani, U., & Emran, T. (2025). Neutrophil‐to‐lymphocyte and monocyte‐to‐lymphocyte ratios as inflammatory markers in the assessment of glycemic status in diabetic patients of Asir region. Animal Models and Experimental Medicine, 8, 1567 - 1578. https://doi.org/10.1002/ame2.70023
21. Donath, M. Y., & Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11(2), 98–107. https://doi.org/10.1038/nri2925
22. Erener, S. (2020). Diabetes, infection risk and COVID-19. Molecular Metabolism, 39. https://doi.org/10.1016/j.molmet.2020.101044
23. Ferlita, S., Yegiazaryan, A., Noori, N., Lal, G., Nguyen, T., To, K., & Venketaraman, V. (2019). Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis. Journal of Clinical Medicine, 8. https://doi.org/10.3390/jcm8122219
24. Flood, D., Seiglie, J., Dunn, M., Tschida, S., Theilmann, M., Marcus, M., Brian, G., Norov, B., Mayige, M., Gurung, M., Aryal, K., Labadarios, D., Dorobanțu, M., Silver, B., Bovet, P., Jørgensen, J., Guwatudde, D., Houehanou, C., Andall-Brereton, G., Quesnel-Crooks, S., Sturua, L., Farzadfar, F., Moghaddam, S., Atun, R., Vollmer, S., Bärnighausen, T., Davies, J., Wexler, D., Geldsetzer, P., Rohloff, P., Ramírez-Zea, M., Heisler, M., & Manne‐Goehler, J. (2021). The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults.. The Lancet. Healthy longevity, 2 6, e340-e351. https://doi.org/10.1016/s2666-7568(21)00089-1
25. Gebremariam, G., Biratu, S., Alemayehu, M., Welie, A., Beyene, K., Sander, B., & Gebretekle, G. (2022). Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in Ethiopia. PLoS ONE, 17. https://doi.org/10.1371/journal.pone.0264199
26. Geng, T., Zhu, K., Lu, Q., Wan, Z., Chen, X., Liu, L., Pan, A., & Liu, G. (2023). Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study. PLOS Medicine, 20. https://doi.org/10.1371/journal.pmed.1004135
27. Green, J., Crowley, M., Thirunavukkarasu, S., Maruthur, N., & Oldenburg, B. (2024). The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice.. Diabetes care. https://doi.org/10.2337/dci24-0001
28. Grossmann, V., Schmitt, V., Zeller, T., Panova-Noeva, M., Schulz, A., Laubert-Reh, D., Juenger, C., Schnabel, R., Abt, T., Laskowski, R., Wiltink, J., Schulz, E., Blankenberg, S., Lackner, K., Münzel, T., & Wild, P. (2015). Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes. Diabetes Care, 38, 1356 - 1364. https://doi.org/10.2337/dc14-3008
29. Hoffmann, L., Kohls, M., Arnolds, S., Achenbach, P., Bergholdt, R., Bonifacio, E., Bosi, E., Gündert, M., Hoefelschweiger, B., Hummel, S., Jarosz-Chobot, P., Kordonouri, O., Lampasona, V., Narendran, P., Overbergh, L., Pociot, F., Raposo, J., Šumník, Z., Szypowska, A., Vercauteren, J., Winkler, C., Mathieu, C., & Ziegler, A. (2025). EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents. BMJ Open, 15. https://doi.org/10.1136/bmjopen-2024-088522
30. Holt, R., Cockram, C., , R., & Luk, A. (2024). Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia, 67, 1168 - 1180. https://doi.org/10.1007/s00125-024-06102-x
31. Iannantuoni, F., Diaz-Morales, N., Escribano-López, I., Solá, E., Roldán-Torres, I., Apostolova, N., Bañuls, C., Rovira-Llopis, S., Rocha, M., & Víctor, V. (2019). Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?. Antioxidants & Redox Signaling, 30, 232 - 240. https://doi.org/10.1089/ars.2018.7582
32. Johansson, M., Åkesson, A., Nilsson, P., & Melander, O. (2024). Longitudinal assessment of the impact of prevalent diabetes on hospital admissions and mortality in the general population: a prospective population-based study with 19 years of follow-up. BMC Public Health, 24. https://doi.org/10.1186/s12889-024-20435-7
33. Kalan, L., Meisel, J., Loesche, M., Horwinski, J., Soaita, I., Chen, X., Uberoi, A., Gardner, S., & Grice, E. (2019). Strain- and Species-Level Variation in the Microbiome of Diabetic Wounds Is Associated with Clinical Outcomes and Therapeutic Efficacy.. Cell host & microbe, 25 5, 641-655.e5. https://doi.org/10.1016/j.chom.2019.03.006
34. Kassahun, C., & Mekonen, A. (2017). Knowledge, attitude, practices and their associated factors towards diabetes mellitus among non diabetes community members of Bale Zone administrative towns, South East Ethiopia. A cross-sectional study. PLoS ONE, 12. https://doi.org/10.1371/journal.pone.0170040
35. Khan, T., Field, D., Chen, V., Ahmad, S., Mejia, S., Kahleová, H., Rahelić, D., Salas‐Salvadó, J., Leiter, L., Uusitupa, M., Kendall, C., & Sievenpiper, J. (2023). Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies. Diabetes Care, 46, 643 - 656. https://doi.org/10.2337/dc22-1024
36. Kim, T., & Choi, S. (2025). Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications. Diabetes & Metabolism Journal, 49, 915 - 933. https://doi.org/10.4093/dmj.2025.0508
37. Koufakis, T., Kouroupis, D., Kourti, A., Thisiadou, K., Karalazou, P., Popovic, D., Patoulias, D., Maltese, G., Pyrpasopoulou, A., Doukelis, P., Zografou, I., Kotsa, K., Doumas, M., & Makedou, K. (2025). Interleukin-6-Related Inflammatory Burden in Type 1 Diabetes: Evidence for Elevation with Suboptimal Glycemic Control. Journal of Clinical Medicine, 14. https://doi.org/10.3390/jcm14186511
38. Levengood, T., Peng, Y., Xiong, K., Song, Z., Elder, R., Ali, M., Chin, M., Allweiss, P., Hunter, C., & Becenti, A. (2019). Team-Based Care to Improve Diabetes Management: A Community Guide Meta-analysis.. American journal of preventive medicine, 57 1, e17-e26. https://doi.org/10.1016/j.amepre.2019.02.005
39. Marfella, R., Sardu, C., D’Onofrio, N., Prattichizzo, F., Scisciola, L., Messina, V., La Grotta, R., Balestrieri, M., Maggi, P., Napoli, C., Ceriello, A., & Paolisso, G. (2022). Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes. Nature Communications, 13. https://doi.org/10.1038/s41467-022-30068-2
40. Măriuț, O., Burlec, A., Macovei, I., Mircea, C., Datcu, M., Hăncianu, M., & Corciovă, A. (2025). Real-World and Clinical Implications of Patient Education, Lifestyle and Treatment Adherence in Romanian Diabetes Care: An Observational Study. Journal of Clinical Medicine, 14. https://doi.org/10.3390/jcm14207171
41. Messina, J., Campbell, S., Morris, R., Eyles, E., & Sanders, C. (2017). A narrative systematic review of factors affecting diabetes prevention in primary care settings. PLoS ONE, 12. https://doi.org/10.1371/journal.pone.0177699
42. Mohanty, S., Kamolvit, W., Scheffschick, A., Björklund, A., Tovi, J., Espinosa, A., Brismar, K., Nyström, T., Schröder, J., Östenson, C., Aspenström, P., Brauner, H., & Brauner, A. (2022). Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder. Nature Communications, 13. https://doi.org/10.1038/s41467-022-32636-y
43. Mousa, A., Naderpoor, N., Teede, H., Scragg, R., & De Courten, B. (2018). Vitamin D supplementation for improvement of chronic low‐grade inflammation in patients with type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials. Nutrition Reviews, 76, 380–394. https://doi.org/10.1093/nutrit/nux077
44. Neupane, S., Florkowski, W., Dhakal, U., & Dhakal, C. (2024). Regional disparities in type 2 diabetes prevalence and associated risk factors in the United States. Diabetes, 26, 4776 - 4782. https://doi.org/10.1111/dom.15797
45. Omotosho, I., Shamsuddin, N., Huri, Z., Chong, W., & Rehman, I. (2025). From Control to Cure: Insights into the Synergy of Glycemic and Antibiotic Management in Modulating the Severity and Outcomes of Diabetic Foot Ulcers. International Journal of Molecular Sciences, 26. https://doi.org/10.3390/ijms26146909
46. Patil, S., Rao, R. S., Majumdar, B., & Anil, S. (2015). Clinical appearance of oral Candida infection and therapeutic strategies. Frontiers in Microbiology, 6, 1391. https://doi.org/10.3389/fmicb.2015.01391
47. Pearson-Stuttard, J., Cheng, Y., Bennett, J., Vamos, E., Zhou, B., Valabhji, J., Cross, A., Ezzati, M., & Gregg, E. (2021). Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. The Lancet. Diabetes & Endocrinology, 10, 46 - 57. https://doi.org/10.1016/s2213-8587(21)00288-6
48. R., L., Weigelt, K., De Wit, H., Ozcan, B., Van Oudenaren, A., Sempértegui, F., Sijbrands, E., Grosse, L., Freire, W., Drexhage, H., & Leenen, P. (2014). Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients. PLoS ONE, 9. https://doi.org/10.1371/journal.pone.0115209
49. Ren, Y., Chen, Y., Zheng, W., Kong, W., Liao, Y., Zhang, J., Wang, M., & Zeng, T. (2025). The effect of GLP‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis. Diabetes, 27, 3607 - 3626. https://doi.org/10.1111/dom.16366
50. Rodrigues, C., Rodrigues, M., & Henriques, M. (2019). Candida sp. Infections in Patients with Diabetes Mellitus. Journal of Clinical Medicine, 8. https://doi.org/10.3390/jcm8010076
51. Rohm, T., Meier, D., Olefsky, J., & Donath, M. (2022). Inflammation in obesity, diabetes, and related disorders.. Immunity, 55 1, 31-55. https://doi.org/10.1016/j.immuni.2021.12.013
52. Saulsberry, L., Gunter, K., O’Neal, Y., Tanumihardjo, J., Gauthier, R., Chin, M., & Peek, M. (2023). “Everything in One Place”: Stakeholder Perceptions of Integrated Medical and Social Care for Diabetes Patients in Western Maryland. Journal of General Internal Medicine, 38, 25-32. https://doi.org/10.1007/s11606-022-07919-1
53. Shakir, W. H., Chyad, L. A., Ghali, Z. H., & Kadhim, A. S. (2025). Prevalence of Anemia and Associated Risk Factors Among Pregnant Women in Al-Aziziyah City, Iraq. Journal of Basic Science, 18(27), 661–680. https://doi.org/10.31185/bsj.Vol18.Iss27.1025
54. Shankar, E., Mohan, V., Premalatha, G., Srinivasan, R., & Usha, A. (2005). Bacterial etiology of diabetic foot infections in South India.. European journal of internal medicine, 16 8, 567-70. https://doi.org/10.1016/j.ejim.2005.06.016
55. Spinetti, G., Mutoli, M., Greco, S., Riccio, F., Ben-Aicha, S., Kenneweg, F., Jusic, A., De Gonzalo-Calvo, D., Nossent, A., Novella, S., Kararigas, G., Thum, T., Emanueli, C., Devaux, Y., & Martelli, F. (2023). Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems. Cardiovascular Diabetology, 22. https://doi.org/10.1186/s12933-023-01842-3
56. Sundaram, M., Kavookjian, J., Patrick, J., Miller, L., Madhavan, S., & Scott, V. (2007). Quality of life, health status and clinical outcomes in Type 2 diabetes patients. Quality of Life Research, 16, 165-177. https://doi.org/10.1007/s11136-006-9105-0
57. Tesch, G. (2017). Diabetic nephropathy - is this an immune disorder?. Clinical science, 131 16, 2183-2199. https://doi.org/10.1042/cs20160636
58. Tibães, J., Silva, M., Azarcoya-Barrera, J., Cervantes, P., Makarowski, A., Mereu, L., & Richard, C. (2025). Assessment of immune function in individuals without and with obesity and normoglycemia, glucose intolerance, or type 2 diabetes: primary findings of the NutrIMM study, a single-arm controlled feeding trial. The American Journal of Clinical Nutrition, 121, 1315 - 1327. https://doi.org/10.1016/j.ajcnut.2025.03.003
59. Vich-Pérez, P., Taulero-Escalera, B., García-Espinosa, V., Villanova-Cuadra, L., Regueiro-Toribio, P., Sevilla-Machuca, I., Timoner-Aguilera, J., Martínez-Grandmontagne, M., Abós-Pueyo, T., Álvarez-Hernández-Cañizares, C., Reviriego-Jaén, G., Serrano-López-Hazas, A., Gala-Molina, I., Sanz-Pascual, M., & Salinero-Fort, M. (2025). Sex and age differences in cardiovascular risk factors and lifestyle in patients recently diagnosed with diabetes mellitus: A cross-sectional study in Spanish primary health care. PLOS ONE, 20. https://doi.org/10.1371/journal.pone.0314519
60. Wada, J., & Makino, H. (2016). Innate immunity in diabetes and diabetic nephropathy. Nature Reviews Nephrology, 12, 13-26. https://doi.org/10.1038/nrneph.2015.175
61. Williams, D., & Lewis, M. (2011). Pathogenesis and treatment of oral candidosis. Journal of Oral Microbiology, 3(1), 5771. https://doi.org/10.3402/jom.v3i0.5771
62. World Health Organization. (2022). Global report on diabetes. World Health Organization. https://www.who.int/publications/i/item/9789241565257
63. Wu, X., Li, G., Liu, L., Li, H., Zhao, Y., Golden, A., & Cai, L. (2025). Changes in pre-diabetes and diabetes prevalence and diabetes self-management behaviors across socioeconomic spectra in rural southwest China: 2013–2022. BMC Public Health, 25. https://doi.org/10.1186/s12889-025-21763-y
64. Zehra, A., Gerstle, D., Ali, F., Ali, M., Mejia-Lancheros, C., & Fazli, G. (2025). A Scoping Review on Community-based Diabetes Screening Interventions: Paving the Pathway to Early Care and Prevention of Diabetes. Current Diabetes Reports, 25. https://doi.org/10.1007/s11892-025-01605-2
65. Zhang, Y., Pan, X., Chen, J., Xia, L., Cao, A., Zhang, Y., Wang, J., Li, H., Yang, K., Guo, K., He, M., & Pan, A. (2019). Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Diabetologia, 63, 21-33. https://doi.org/10.1007/s00125-019-04985-9
Downloads
Published
Issue
Section
License
Copyright (c) 2026 م.م. ليث عمار چياد جامعة واسط /كلية التربية الاساسية /قسم العلوم، ا.م.د علي سعد البديري جامعة واسط /كلية التربية الاساسية /قسم العلوم، م.م. وسام حسيب شاكر جامعة واسط /كلية التربية الاساسية /قسم العلوم
This work is licensed under a Creative Commons Attribution 4.0 International License.
